Showing results (291-300 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|October 14, 2021
Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trialBhanu Gupta, Kok-Seng Chee, Li-Qi Neo, et al.Therapeutic Advances in Psychopharmacology|July 14, 2022
Vortioxetine as adjunctive therapy in the treatment of schizophreniaSofia Redaelli, Lilla Porffy, Ebenezer Oloyede, et al.Therapeutic Advances in Psychopharmacology|July 14, 2022
Exercise interventions to reduce anxiety in mid-life and late-life anxiety disorders and subthreshold anxiety disorder: a systematic reviewTerence W H Chong, Scherazad Kootar, Helen Wilding, et al.Therapeutic Advances in Psychopharmacology|June 18, 2019
A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazineRikinkumar S Patel, Zeeshan Mansuri, Fatima Motiwala, et al.Therapeutic Advances in Psychopharmacology|February 3, 2022
Brugada syndrome: should we be screening patients before prescribing psychotropic medication?Azizah Attard, Claire Stanniland, Stephen Attard, et al.Therapeutic Advances in Psychopharmacology|February 21, 2022
Long-acting injectable aripiprazole in pregnant women with schizophrenia: a case-series reportBlanca Fernández-Abascal, Maria Recio-Barbero, Margarita Sáenz-Herrero, et al.Therapeutic Advances in Psychopharmacology|February 21, 2022
Landmarks of pharmacogenomics and some considerations for clinical practiceDavid Nana AmpongTherapeutic Advances in Psychopharmacology|May 26, 2017
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studiesRafael G Dos Santos, José Carlos Bouso, Jaime E C HallakTherapeutic Advances in Psychopharmacology|July 7, 2018
Rethinking the spectrum of mood disorders: implications for diagnosis and management - Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, FranceRoger S McIntyre, Allan H Young, Peter M HaddadTherapeutic Advances in Psychopharmacology|April 23, 2019
Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disordersLex WunderinkPageof 55